Constantine Chinoporos serves as Executive at Applied Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Constantine Chinoporos has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 3, 2026 involved transacting 57,111 shares valued at $0.
Constantine Chinoporos currently holds 57,111 shares of Applied Therapeutics, Inc. (APLT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Constantine Chinoporos has been a net neutral trader of APLT stock. They have purchased $0 and sold $0 worth of shares.
Constantine Chinoporos's most recent insider trade was on Feb 3, 2026, when they sold 57,111 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 19, 2025 | APLT | $0 | Award | 437,500 | $N/A | Discretionary |
| Dec 28, 2023 | APLT | $0 | Award | 300,000 | $N/A | Discretionary |